Pharmacokinetics, safety and efficacy of an optimized dose of artemether–lumefantrine in the treatment of acute uncomplicated Plasmodium falciparum malaria in neonates and infants of less than 5 kg body weight: a multicentre, open-label, single-arm p
Pharmacokinetics, safety and efficacy of an optimized dose of artemether–lumefantrine in the treatment of acute uncomplicated Plasmodium falciparum malaria in neonates and infants of less than 5 kg body weight: a multicentre, open-label, single-arm p
Anne Claire Marrast, Céline Risterucci, Cornelis Winnips, Preetam Gandhi et al.
Journal
Tropical Medicine and Health
Topics
Malaria Research and Control
article
Pharmacokinetics, safety and efficacy of an optimized dose of artemether–lumefantrine in the treatment of acute uncomplicated Plasmodium falciparum malaria in neonates and infants of less than 5 kg body weight: a multicentre, open-label, single-arm p
Anne Claire Marrast, Céline Risterucci, Cornelis Winnips, Preetam Gandhi, Alfred B. Tiono, Sarfaraz Sayyed, Katalin Csermak Renner, Issaka Sagara, Vinay Kumar Venishetty, Christine Manyando, Ivan Demin, Gerda Hofstetter, Myriam El Gaaloul, Marc Cousin, Zhiyan Qian, Bernhards Ragama Ogutu, Quique Bassat, Bérenger Kaboré, Jie Zhang, Guoqin Su, Gildas Wounounou, Sophie Hugot, Stefan Schneitter
article en
Abstract
No abstract available for this paper.
Publication Tag
Tropical Medicine and HealthVol. 53(1)
Institutions
Institució Catalana de Recerca i Estudis Avançats (ES), Novartis (Switzerland) (CH), Swiss Tropical and Public Health Institute (CH), Strathmore University (KE), University of Basel (CH), Instituto de Salud Carlos III (ES), Kinshasa General Hospital (CD), Kenya Medical Research Institute (KE), Novartis (India) (IN), Departament de Salut (ES), Université des Sciences, des Techniques et des Technologies de Bamako (ML), Hospital Clínic de Barcelona (ES), Novartis (United States) (US), Manhiça Health Research Centre (MZ), Tropical Diseases Research Centre (ZM), Barcelona Institute for Global Health (ES), Groupe de Recherche et d’Action sur le Foncier (BF), Institut de Recherche en Sciences de la Santé (BF), Medicines for Malaria Venture (CH), Universitat de Barcelona (ES)